N-Boc-Phe-Leu-Phe-Leu-Phe
CAS No. 148182-34-7
N-Boc-Phe-Leu-Phe-Leu-Phe ( Boc-FLFLF )
产品货号. M22305 CAS No. 148182-34-7
N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥640 | 有现货 |
|
5MG | ¥988 | 有现货 |
|
10MG | ¥1847 | 有现货 |
|
25MG | ¥3151 | 有现货 |
|
50MG | ¥4641 | 有现货 |
|
100MG | ¥6610 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称N-Boc-Phe-Leu-Phe-Leu-Phe
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
-
产品描述N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.
-
同义词Boc-FLFLF
-
通路Others
-
靶点Other Targets
-
受体FPR1
-
研究领域——
-
适应症——
化学信息
-
CAS Number148182-34-7
-
分子量785.97
-
分子式C44H59N5O8
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)C[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Schepetkin IA, et al. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones. Biochem Pharmacol. 2014 Dec 15;92(4):627-41.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Methyl caffeate acid
Methyl caffeate acid.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.